PreveCeutical Medical Inc

As of June 30, 2026, PreveCeutical Medical Inc carries a market capitalization of 12.43M, placing it among publicly traded companies globally. Its enterprise value stands at 17.24M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, PreveCeutical Medical Inc has 621.59M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, PreveCeutical Medical Inc maintains a current ratio of 0.16, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities.

As of the close on September 29, 2026, PreveCeutical Medical Inc's stock has declined approximately 33.33% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.02.

As of June 30, 2026, PreveCeutical Medical Inc holds 35,660.00 in cash and equivalents against 4.84M in total debt, resulting in a net debt position of 4.81M. Total book value stands at -6.69M, with working capital of -6.38M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

PreveCeutical Medical Inc's most recent stock split took place on May 23, 2018 with a 1:5 split ratio.